Sharlene M. Day, MD
Cardiology

Sharlene M. Day, MD

Cardiology
Accepting new patients
Sees patients age 16 and up
Penn Heart and Vascular Center
Penn Medicine Provider

About me

  • Director, Translational Research, Division of Cardiovascular Medicine and Cardiovascular Institute
  • Presidential Professor

My education and training

  • New York University School of MedicineMedical School
  • University of Michigan HealthResidency
  • University of Michigan HealthFellowship
Watch video featuring Sharlene M. Day, MD on YouTube

Spoken languages

English
English

Reviews

Average Rating

332 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
August 2026
explained all tests results and questions
Anonymous
August 2026
excellent doctor that actually knows what she is doing
Anonymous
August 2026
awesome visit
Anonymous
July 2026
dr. day is very knowledgeable, and has great communication skills. she's also very kind.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Day is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Walsh R, Mazzarotto F, Whiffin N, Buchan R, Midwinter W, Wilk A, Li N, Felkin L, Ingold N, Govind R, Ahm,ad M, Mazaika E, Allouba M, Zhang X, de Marvao A, Day SM, Ashley E, Colan SD, Michels M, Pereira AC, Jacoby D, Ho CY, Thomson KL, Watkins H, Barton PJR, Olivotto, I, Cook SA, Ware JS. Quantitative Approaches to Variant Classification Increase the Yield and Precision of Genetic Testing for Mendelian Diseases: The Case for Hypertrophic Cardiomyopathy. , Genome Medicine, 11(1): 2019,5


Garratt M, Leander D, Pifer K, Herrera J, Day SM, Fiehn O, Brooks S, Miller RA. 17-alpha Estradiol Ameliorates Age-Associated Sarcopenia and Improves Late Life Physical Function in Male Mice But Not in Females or Castrated Males , Aging Cell, 18(2): 2019,e12920


Day SM Nonobstructive Hypertrophic Cardiomyopathy: The High Hanging Fruit. , JAMA Cardiol, 4(3): 2019,235-236


Vigneault DM, Yang E, Jensen PJ, Tee MW, Farhad H, Chu L, Noble JA, Day SM, Colan SD, Russell MW, Towbin J, Sherrid MV, Canter CE, Shi L, Ho CY, Bluemke DA Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking. , Radiology, 290(3): 2019,640-48


Smith ED, Tome J, Mcgrath R, Kumar S, Concannon M, Day SM, Saberi S, Helms AS Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death. , Int J Cardiol, 274: 2019,226-231


O'Leary TS, Snyder J, Sadayappan S, Day SM, Previs MJ MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy. , J Mol Cell Cardiol, 127: 2019,165-173


Glazier AA, Thompson A, Day SM Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy. , Pflugers Arch, 471(5): 2019,781-793


Ho CY, Day, SM, Ashley EA, Michels M, Pereira A, Jacoby D, Fox J, Caleshu C, Cirino AL, Ware J, Helms AS, Colan SD, Signorovich J, Green E, Olivotto I Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). , Circulation, 138(14): 2018,1387-98


Lee SP, Ashley EA, Homburger J, Caleshu C, Green EM, Jacoby D, Colan SD, Arteaga-Fernández E, Day SM, Girolami F, Olivotto I, Michels M, Ho CY, Perez MV, SHaRe Investigators Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy. , Circ Heart Fail, 11(9): 2018,e005191


Glazier AA, Hafeez N, Mellacheruvu D, Basrur V, Nesvizhskii AI, Lee LM, Shao H, Tang V, Yob JM, Gestwicki JE, Helms AS, Day SM HSC70 is a chaperone for wild-type and mutant cardiac myosin binding protein C. , JCI Insight, 3(11): 2018,pii: 99319


View all publications